Jun 25, 2026 09:10AM
Jun 23, 2026 09:25AM
Jun 17, 2026 09:25AM
Jun 9, 2026 09:25AM
Jun 9, 2026 09:25AM
Jun 3, 2026 09:25AM
May 19, 2026 09:15AM Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 7, 2026 09:25AM
May 5, 2026 09:11AM
May 5, 2026 09:10AM
May 1, 2026 09:25AM
Apr 29, 2026 09:10AM
Apr 29, 2026 09:10AM
Apr 23, 2026 09:05AM Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
Apr 21, 2026 09:10AM
Apr 15, 2026 09:10AM
Apr 7, 2026 09:10AM
Apr 7, 2026 09:10AM
Apr 1, 2026 09:20AM
Apr 1, 2026 09:20AM
Mar 26, 2026 09:20AM Lexaria receives 5 new patents including diabetes and hypertension treatments
Mar 26, 2026 09:20AM
Mar 24, 2026 09:15AM
Mar 24, 2026 09:15AM
Mar 4, 2026 09:25AM
Mar 4, 2026 09:25AM
Feb 5, 2026 09:15AM
Jan 22, 2026 09:22AM Lexaria receives six new patents, bringing total to 60 worldwide
Jan 22, 2026 09:20AM
Jan 12, 2026 09:10AM
Jan 12, 2026 09:10AM
Dec 30, 2025 09:20AM
Dec 30, 2025 09:20AM
Dec 29, 2025 05:13PM
Dec 26, 2025 06:42AM Lexaria Bioscience (LEXX) PT Lowered to $1.50 at H.C. Wainwright
Dec 23, 2025 09:29AM
Dec 23, 2025 09:29AM
Dec 16, 2025 04:00PM
Dec 16, 2025 04:00PM
Dec 15, 2025 08:01AM
Dec 15, 2025 08:00AM
Dec 5, 2025 04:03PM Lexaria Bioscience (LEXX) files for 2.76M share offering by selling stockholders
Nov 12, 2025 09:11AM
Nov 12, 2025 09:10AM
Oct 9, 2025 09:20AM
Oct 9, 2025 09:20AM
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM
Sep 26, 2025 08:00AM Lexaria Bioscience raises $4 million in registered direct offering
Sep 26, 2025 08:00AM

409,002 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All